Ask AI
ProCE Banner Events

Share

Updates in CLL/SLL Care: Expert Guidance for the Multidisciplinary Teams in Veterans Health Administration Systems [Open Registration]

Register now for this interactive, case-based workshop series to effectively personalize the care of patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and how to incorporate approved and emerging agents and treatment combinations into their care. After the meeting, download the associated slideset for use in your clinic.

Nurse Practitioners/Nurses: 1.00 Nursing contact hour

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

This event has expired. No longer available for credits.

Credits Available

1.0

Who Should Attend

This program is intended for oncologists, nurses, pharmacists, and other healthcare professionals on the multidisciplinary team caring for veterans with CLL.

Time and location

Wednesday, January 03, 2024

11:30 AM - 12:30 PM Eastern Time (ET)

Virtual

CCO Simulcast | Host Group OH
Dayton, Ohio

Agenda

  • Introduction
  • Recent advances in the treatment of CLL/SLL
    • Overview of CLL and current treatment algorithm
    • Key Variables in Making Treatment Decisions
    • Emerging therapies in CLL/SLL
  • Case Discussions
    • Mastering the Components of the Current Treatment Regimens
    • Classes of Agents: Mechanisms of Action, Selectivity, Specificity, Development of Resistance and Intolerance, and Associated Adverse Events
    • Drug-Drug Interactions
  • Partnering With Patients in Their Care
    • Strategies to Promote Adherence
    • Long-Term Survival Considerations
    • Roles of the multidisciplinary care team in CLL/SLL Care
  • Final Thoughts and Audience Question and Answer Session

Location

Venue Name

CCO Simulcast | Host Group OH

Address

CCO Simulcast | Host Group OH
Dayton, Ohio

CME/CE Info

Program Overview
This program will provide expert perspectives to facilitate optimal clinical management approaches for patients with CLL/SLL, including information on the latest practice impacting data on recent advances in the personalization of care of patients with CLL/SLL. 

Goal Statement
This activity aims to improve learners’ knowledge, competence, and performance in applying practice-changing clinical data and expert recommendations to optimally integrate the use of currently available therapies for their patients with CLL. 

Target Audience
This program is intended for oncologists, nurses, pharmacists, and other healthcare professionals on the multidisciplinary team caring for veterans with CLL. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Plan therapeutic approaches for treatment-naive and relapsed/refractory CLL/SLL, including consideration of the agent’s toxicity profile, prognostic variables, comorbidities, and patient preference
  • Develop treatment plans to address unique clinical challenges based on the available evidence and the recommendations outlined in recognized guidelines to optimize outcomes for veterans with CLL/SLL
  • Appraise intraclass differences in selectivity, binding, efficacy, and adverse event profiles among agents with a similar molecular target used to treat CLL/SLL
  • Evaluate the evolving role of noncovalent BTK inhibitors, measurable/minimal residual disease, allogeneic hematopoietic cell transplant, and CAR T-cell therapy in the therapeutic strategy for veterans with CLL

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-23-199-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by educational grants from AstraZeneca and Lilly.

Contact Information

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.